Berkovich, Regina MD, PhD Inc.
1 clinical trials · Sponsor
◉ Watch Berkovich, Regina MD, PhD Inc.
| Record | Firm | Date |
|---|---|---|
| A Pilot Study to Characterize the Biological Effect of a Pre-planned 12 Week Dose Interruption of Natalizumab (NCT04048577) | Berkovich, Regina MD, PhD Inc. | 2019-07-03 |
Track Berkovich, Regina MD, PhD Inc. automatically
Every clearance here is in the API, with alerts when new ones post.